MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, S. C.
Right arrow Articles by Miller, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, S. C.
Right arrow Articles by Miller, K. W.

Channel inhibition by alkanols occurs at a binding site on the nicotinic acetylcholine receptor

SC Wood, PH Tonner, AJ de Armendi, B Bugge and KW Miller

Department of Anaesthesia, Massachusetts General Hospital, Boston.

The mechanism by which normal alkanols longer than ethanol inhibit cation flux through the transient open state of the nicotinic acetylcholine receptor (nAcChoR) is unknown. They might act nonspecifically either by perturbing the lipid bilayer or by binding to many low affinity sites. Alternatively, they might act in a mutually exclusive manner at a well defined site on the protein. To address this problem, a rapid assay of agonist-induced 86Rb+ efflux from nAcChoR- rich Torpedo membrane vesicles was used that enabled the anesthetic- induced inhibition to be measured on a millisecond time scale, under conditions where the concentration of all ligands was raised in < 1 msec, thereby avoiding complications due to desensitization. By measuring the inhibition constant of one agent as a function of the fixed concentration of a second agent, it is possible to distinguish between nonspecific action and mutually exclusive action. Our data are inconsistent with the hypothesis that 1-octanol and 1-heptanol act in a nonspecific manner, but they are consistent with the hypothesis that these two alkanols act in a mutually exclusive manner at a well defined site. The data suggest that the alkanols sterically compete for the site, but experimental limitations prevented a less plausible model, in which there is a strong negative allosteric interaction between separate octanol and heptanol sites, from being ruled out. Should the latter interaction occur, the data indicate that occupation of one alkanol site would decrease the affinity of the other by about 50-fold. The local anesthetic procaine is known to act in a mutually exclusive manner with the agonist self-inhibition site. We found that octanol and procaine acted as separate sites, which exhibited a negative heterotrophic interaction such that octanol reduced the affinity of procaine 6-fold. We conclude that octanol and heptanol inhibit cation flux through the channel of the nAcChoR by binding to a site (or a set of sites of equal affinity) whose location is distinct from, but allosterically coupled to, the agonist self-inhibition site.

Volume 47, Issue 1, pp. 121-130, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
NEJMHome page
J. A. Campagna, K. W. Miller, and S. A. Forman
Mechanisms of Actions of Inhaled Anesthetics
N. Engl. J. Med., May 22, 2003; 348(21): 2110 - 2124.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
K. W. Miller
The nature of sites of general anaesthetic action
Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. L. Godden, R. A. Harris, and T. V. Dunwiddie
Correlation between Molecular Volume and Effects of n-Alcohols on Human Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 716 - 722.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Narahashi
Neuroreceptors and Ion Channels as the Basis for Drug Action: Past, Present, and Future
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 1 - 26.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Hann, O. R. Pagán, L. Gregory, T. Jácome, A. D. Rodríguez, P. A. Ferchmin, and R. Lu
Characterization of Cembranoid Interaction with the Nicotinic Acetylcholine Receptor
J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 253 - 260.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. G. Eckenhoff and J. S. Johansson
Molecular Interactions Between Inhaled Anesthetics and Proteins
Pharmacol. Rev., December 1, 1997; 49(4): 343 - 368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Covarrubias, T. B. Vyas, L. Escobar, and A. Wei
Alcohols Inhibit a Cloned Potassium Channel at a Discrete Saturable Site
J. Biol. Chem., August 18, 1995; 270(33): 19408 - 19416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Pratt, S. S. Husain, K. W. Miller, and J. B. Cohen
Identification of Sites of Incorporation in the Nicotinic Acetylcholine Receptor of a Photoactivatible General Anesthetic
J. Biol. Chem., September 15, 2000; 275(38): 29441 - 29451.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics